全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Computational Analysis of Sulfonamide-Based Compounds by Molecular Docking and ADME/T in the Inhibition of Acetylcholinesterase (AChE) in Alzhaimer’s Disease

DOI: 10.4236/oalib.1108469, PP. 1-13

Subject Areas: Computational Biology

Keywords: Alzheimer, AChE, Sulfonamides, Docking, ADMET

Full-Text   Cite this paper   Add to My Lib

Abstract

Alzheimer’s disease is a long-term neurodegenerative disease that degenerates brain cells and causes severe cognitive impairment in humans. Acetylcholinesterase inhibition is a common approach to improve the well-being of AD patients by increasing the duration of acetylcholine in cholinergic synapses. Despite the development of drugs with this utility, none of them is still clinically significant. In this sense, it is sought through studies the development of new drugs, as well as to improve the pharmacological activity of the compounds already used. Six compounds of the sulfonamida’s base (sulfafurazole, sulfadiazine, sulfamethazine, sulfasalazine, sulfamethoxazole and sulfacetamide), already used for the treatment of other pathologies, were investigated by computational methods to know the molecular docking and analysis of absorption, distribution, metabolism and excretion (ADME). The results showed that these compounds presented a good interaction in relation to acetylcholinesterase (AChE) and a relative affinity to the inhibition sites of the enzyme. The in sílico study showed that these drugs have a good human intestinal absorption, besides not being toxic, carcinogenic, mutagenic and neither have inhibitory capacity of cytochrome P (CYP).

Cite this paper

Lima, C. C. , Silva, D. S. N. and Sá, E. R. A. D. (2022). Computational Analysis of Sulfonamide-Based Compounds by Molecular Docking and ADME/T in the Inhibition of Acetylcholinesterase (AChE) in Alzhaimer’s Disease . Open Access Library Journal, 9, e8469. doi: http://dx.doi.org/10.4236/oalib.1108469.

References

[1]  George, E.K. and Reddy, P.H. (2019) Can Healthy Diets, Regular Exercise, and Better Lifestyle Delay the Progression of Dementia in Elderly Individuals? Journal of Alzheimer’s Disease Reports, 72, S37-S58. https://doi.org/10.3233/jad-190232
[2]  Vijayakumar, S., Manogar, P., Prabhu, S., and Sanjeevkumar Singh, R.A. (2018) Novel Ligand-Based Docking; Molecular Dynamic Simulations; and Absorption, Distribution, Metabolism, and Excretion Approach to Analyzing Potential Acetylcholinesterase Inhibitors for Alzheimer’s Disease. Journal of Pharmaceutical Analysis, 8, 413-420. https://doi.org/10.1016/j.jpha.2017.07.006
[3]  Taha, M., Alshamrani, F., Rahim, F., Rahim, F., El Hassane, A., Uddin, N., et al. (2021) Synthesis, Characterization, Biological Evaluation, and Kinetic Study of Indole Base Sulfonamide Derivatives as Acetylcholinesterase Inhibitors in Search of Potent Anti-Alzheimer Agent. Journal of King Saud University: Science, 33, Article ID: 101401. https://doi.org/10.1016/j.jksus.2021.101401
[4]  John, A. and Reddy, P.H. (2020) Synaptic Basis of Alzheimer’s Disease: Focus on Synaptic Amyloid Beta, P-Tau and Mitochondria. Ageing Research Reviews, 65, Article ID: 101208. https://doi.org/10.1016/j.arr.2020.101208
[5]  “Dementia.” https://www.who.int/en/news-room/fact-sheets/detail/dementia
[6]  Crous-bou, M., Minguillón, C., Gramunt, N. and Molinuevo, J.L. (2017) Alzheimer’s Disease Prevention: From Risk Factors to Early Intervention. Alzheimer’s Research & Therapy, 9, Article No. 71. https://doi.org/10.1186/s13195-017-0297-z .
[7]  Liang, C., Li, D.-J., Yang, F.-C., Tseng, P.-T., Carvalho, A.F., Stubbs, B., et al. (2021) Mortality Rates in Alzheimer’s Disease and Non-Alzheimer’s Dementias: A Systematic Review and Meta-Analysis, The Lancet Healthy Longevity, 2, 479-488. https://doi.org/10.1016/S2666-7568(21)00140-9
[8]  Upaganlawar, A.B., Wankhede, N.L., Kale, M.B., Umare, M.D., Sehgal, A., Singh, S., et al. (2021) Interweaving Epilepsy and Neurodegeneration: Vitamin E as a Treatment Approach. Biomedicine & Pharmacotherapy, 143, Article ID: 112146. https://doi.org/10.1016/j.biopha.2021.112146
[9]  Savelieff, M.G., Lee, S., Liu, Y. and Lim, M.H. (2013) Untangling Amyloid-β, Tau, and Metals in Alzheimer’s Disease. ACS Chemical Biology, 8, 856-865. https://doi.org/10.1021/cb400080f
[10]  Türkes, C., Arslan, M., Demir, Y., Çoçaj, L., Rifati Nixha, A. and Beydemir, S. (2019) Synthesis, Biological Evaluation and in Silico Studies of Novel N-Substituted Phthalazine Sulfonamide Compounds as Potent Carbonic Anhydrase and Acetylcholinesterase Inhibitors. Bioorganic Chemistry, 89, Article ID: 103004. https://doi.org/10.1016/j.bioorg.2019.103004
[11]  Yamali, C., Gul, H.I., Kazaz, C., Levent, S. and Gulcin, I. (2020) Synthesis, Structure Elucidation, and in Vitro Pharmacological Evaluation of Novel Polyfluoro Substituted Pyrazoline Type Sulfonamides as Multi-Target Agents for Inhibition of Acetylcholinesterase and Carbonic Anhydrase I and II Enzymes. Bioorganic Chemistry, 96, Article ID: 103627. https://doi.org/10.1016/j.bioorg.2020.103627
[12]  Bousada, G.M., de Sousa, B.L., Furlani, G., Agrizzi, A.P., Ferreira, P.G., Leite, J.P.V., et al. (2020) Tyrosol 1,2,3-Triazole Analogues as New Acetylcholinesterase (AChE) Inhibitors. Computational Biology and Chemistry, 88, Article ID: 107359. https://doi.org/10.1016/j.compbiolchem.2020.107359
[13]  Sibanyoni, M.N., Chaudhary, S.K., Chen, W., Adhami, H.R., Combrinck, S., Maharaj, V., et al. (2020) Isolation, in Vitro Evaluation and Molecular Docking of Acetylcholinesterase Inhibitors from South African Amaryllidaceae. Fitoterapia, 146, Article ID: 104650. https://doi.org/10.1016/j.fitote.2020.104650
[14]  Habtemariam, S. (2019) Natural Products in Alzheimer’s Disease Therapy: Would Old Therapeutic Approaches Fix the Broken Promise of Modern Medicines? Molecules, 24, Article No. 1519. https://doi.org/10.3390/molecules24081519
[15]  Subramaniyan, V., Palani, M., Srinivasan, P., Singh, S.K., Palani, M. and Singh, S.K. (2017) Novel Ligand-Based Docking; Molecular Dynamic Simulations; and Absorption, Distribution, Metabolism, and Excretion Approach to Analyzing Potential Acetylcholinesterase Inhibitors for Alzheimer’s Disease. Journal of Pharmaceutical Analysis, 8, 413-420. https://doi.org/10.1016/j.jpha.2017.07.006
[16]  Shaikh, S., Dhavan, P., Pavale, G., Ramana, M.M.V. and Jadhav, B.L. (2020) Design, Synthesis and Evaluation of Pyrazole Bearing α-Aminophosphonate Derivatives as Potential Acetylcholinesterase Inhibitors against Alzheimer’s Disease. Bioorganic Chemistry, 96, Article ID: 103589. https://doi.org/10.1016/j.bioorg.2020.103589
[17]  Tumiatti, V., Minarini, A., Bolognesi, M.L., Milelli, A., Rosini, M. and Melchiorre, C. (2010) Tacrine Derivatives and Alzheimer’s Disease. Current Medicinal Chemistry, 17, 1825-1838. https://doi.org/10.2174/092986710791111206
[18]  Vadabingi, N., Avula, V.K.R., Zyryanov, G.V., Vallela, S., Anireddy, J.S., Pasupuleti, V.R., et al. (2020) Multiple Molecular Targets Mediated Antioxidant Activity, Molecular Docking, ADMET, QSAR and Bioactivity Studies of Halo Substituted Urea Derivatives of α-Methyl-L-DOPA. Bioorganic Chemistry, 97, Article ID: 103708. https://doi.org/10.1016/j.bioorg.2020.103708
[19]  Krátky, M., Vinsová, J., Volková, M., Buchta, V., Trejtnar, F. and Stolaríková, J. (2012) Antimicrobial Activity of Sulfonamides Containing 5-Chloro-2-Hydroxy- benzaldehyde and 5-Chloro-2-Hydroxybenzoic Acid Scaffold. European Journal of Medicinal Chemistry, 50, 433-440. https://doi.org/10.1016/j.ejmech.2012.01.060
[20]  Parai, M.K., Panda, G., Srivastava, K. and Kumar, S. (2008) Design, Synthesis and Antimalarial Activity of Benzene and Isoquinoline Sulfonamide Derivatives Q. Bioorganic & Medicinal Chemistry Letters, 18, 776-781. https://doi.org/10.1016/j.bmcl.2007.11.038
[21]  Scarpini, E., Scheltens, P. and Feldman, H. (2003) Review Treatment of Alzheimer’s Disease: Current Status and New Perspectives. Lancet Neurology, 2, 539-547. https://doi.org/10.1016/s1474-4422(03)00502-7
[22]  Gul, H.I., Mete, E., Eren, S.E., Sakagami, H., Yamali, C. and Supuran, C.T. (2016) Designing, Synthesis and Bioactivities of 4-[3-(4-Hydroxyphenyl)-5-Aryl-4,5-Dihydr- opyrazol-1-yl]Benzenesulfonamides. Journal of Enzyme Inhibition and Medicinal Chemistry, 32, 169-175. https://doi.org/10.1080/14756366.2016.1243536
[23]  Palakurthy, N.B. and Mandal, B. (2011) Sulfonamide Synthesis Using N-Hydroxy- benzotriazole Sulfonate: An Alternative to Pentafluorophenyl (PFP) and Trichlorophenyl (TCP) Esters of Sulfonic Acids. Tetrahedron Letters, 52, 7132-7134.
[24]  Pettersen, E.F., Goddard, T.D., Huang, C.C., Couch, G.S., Greenblatt, D.M., Meng, E.C., et al. (2004) UCSF Chimera—A Visualization System for Exploratory Research and Analysis. Journal of Computational Chemistry, 25, 1605-1612. https://doi.org/10.1002/jcc.20084
[25]  Trott, O. and Olson, A.J. (2009) Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. Journal of Computational Chemistry, 31, 455-461. https://doi.org/10.1002/jcc.21334
[26]  Srivastava, V., Yadav, A. and Sarkar, P. (2020) Molecular Docking and ADMET Study of Bioactive Compounds of Glycyrrhiza glabra against Main Protease of SARS-CoV2. Materials Today: Proceedings, 49, 2999-3007. https://doi.org/10.1016/j.matpr.2020.10.055
[27]  Carlos, H.T.P., Leiria, V., Carvalho, I. and Taft, C.A. (2006) Molecular Modeling, Docking and ADMET Studies Applied to the Design of a Novel Hybrid for Treatment of Alzheimer’s Disease. Journal of Molecular Graphics and Modelling, 25, 169-175. https://doi.org/10.1016/j.jmgm.2005.12.002
[28]  Cos, E.D., Demiray, S., Ozsoy, N., Demiray, S. and Ozsoy, N. (2021) Anticholinesterase Activities of Novel Indole-Based Hydrazide-Hydrazone Derivatives: Design, Synthesis, Biological Evaluation, Molecular Docking Study and in Silico ADME Prediction. Journal of Molecular Structure, 1247, Article ID: 131398. https://doi.org/10.1016/j.molstruc.2021.131398

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413